{"id":"https://openalex.org/W58047943","doi":"https://doi.org/10.1055/s-0038-1656122","title":"Multicenter Retrospective Study on the Utilization of FEIBA in France in Patients with Factor VIII and Factor IX Inhibitors","display_name":"Multicenter Retrospective Study on the Utilization of FEIBA in France in Patients with Factor VIII and Factor IX Inhibitors","publication_year":1997,"publication_date":"1997-01-01","ids":{"openalex":"https://openalex.org/W58047943","doi":"https://doi.org/10.1055/s-0038-1656122","mag":"58047943","pmid":"https://pubmed.ncbi.nlm.nih.gov/9241742"},"language":"en","primary_location":{"id":"doi:10.1055/s-0038-1656122","doi":"https://doi.org/10.1055/s-0038-1656122","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-0038-1656122","pdf_url":null,"source":{"id":"https://openalex.org/S206235894","display_name":"Thrombosis and Haemostasis","issn_l":"0340-6245","issn":["0340-6245","2567-689X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Thrombosis and Haemostasis","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017113740","display_name":"Claude N\u00e9grier","orcid":"https://orcid.org/0000-0002-2905-055X","observed_orcids":["https://orcid.org/0000-0002-2905-055X","https://orcid.org/0000-0003-3569-0366"]},"institutions":[{"id":"https://openalex.org/I4210123600","display_name":"H\u00f4pital Edouard Herriot","ror":"https://ror.org/02qt1p572","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210100596","https://openalex.org/I4210123600"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"C Negrier","raw_affiliation_strings":["The Hemophilia Comprehensive Care Centers, H\u00f4pita1 Edouard Herriot, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Hemophilia Comprehensive Care Centers, H\u00f4pita1 Edouard Herriot, Lyon, France","institution_ids":["https://openalex.org/I4210123600"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082784881","display_name":"Jenny Goudemand","orcid":"https://orcid.org/0000-0003-3019-3299","observed_orcids":["https://orcid.org/0000-0003-3019-3299"]},"institutions":[{"id":"https://openalex.org/I4210155195","display_name":"H\u00f4pital Claude Huriez","ror":"https://ror.org/05cpv3t46","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406","https://openalex.org/I4210155195"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"J Goudemand","raw_affiliation_strings":["The Hemophilia Comprehensive Care Centers, H\u00f4pital Claude Huriez, Lille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Hemophilia Comprehensive Care Centers, H\u00f4pital Claude Huriez, Lille, France","institution_ids":["https://openalex.org/I4210155195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109329209","display_name":"Sultan Y","orcid":"https://orcid.org/0000-0002-7588-3093","observed_orcids":["https://orcid.org/0000-0002-7588-3093"]},"institutions":[{"id":"https://openalex.org/I4210092774","display_name":"H\u00f4pital Cochin","ror":"https://ror.org/00ph8tk69","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210092774","https://openalex.org/I4210097159","https://openalex.org/I4210124464"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Y Sultan","raw_affiliation_strings":["The Hemophilia Comprehensive Care Centers, H\u00f4pital Cochin, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Hemophilia Comprehensive Care Centers, H\u00f4pital Cochin, Paris, France","institution_ids":["https://openalex.org/I4210092774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054764079","display_name":"Marie-Anne Bertrand","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210136727","display_name":"H\u00f4pital Saint-Jacques","ror":"https://ror.org/03n6qxm88","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210087978","https://openalex.org/I4210136727"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"M Bertrand","raw_affiliation_strings":["The Hemophilia Comprehensive Care Centers, H\u00f4pital Saint Jacques, Besan\u00e7on, Bordeaux, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Hemophilia Comprehensive Care Centers, H\u00f4pital Saint Jacques, Besan\u00e7on, Bordeaux, France","institution_ids":["https://openalex.org/I4210136727"]}]},{"author_position":"middle","author":{"id":null,"display_name":"C Rothschild","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1288880153","display_name":"H\u00f4pital Necker-Enfants Malades","ror":"https://ror.org/05tr67282","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I1288880153","https://openalex.org/I4210097159","https://openalex.org/I4210120235"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"C Rothschild","raw_affiliation_strings":["The Hemophilia Comprehensive Care Centers, H\u00f4pital Necker, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Hemophilia Comprehensive Care Centers, H\u00f4pital Necker, Paris, France","institution_ids":["https://openalex.org/I1288880153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090655390","display_name":"P. Lauroua","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018323443","display_name":"Centre Hospitalier Universitaire de Bordeaux","ror":"https://ror.org/01hq89f96","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018323443"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"P Lauroua","raw_affiliation_strings":["The Hemophilia Comprehensive Care Centers, Centre de Transfusion Sanguine, Bordeaux, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Hemophilia Comprehensive Care Centers, Centre de Transfusion Sanguine, Bordeaux, France","institution_ids":["https://openalex.org/I3018323443"]}]},{"author_position":"last","author":{"id":null,"display_name":"the members of the French FEIBA study group","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"the members of the French FEIBA study group","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.0763,"has_fulltext":false,"cited_by_count":274,"citation_normalized_percentile":{"value":0.94073705,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"77","issue":"06","first_page":"1113","last_page":"1119"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11280","display_name":"Hemophilia Treatment and Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11280","display_name":"Hemophilia Treatment and Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10693","display_name":"Blood transfusion and management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2704","display_name":"Biochemistry (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/feiba","display_name":"FEIBA","score":0.9399999976158142},{"id":"https://openalex.org/keywords/factor-viii-inhibitors","display_name":"factor VIII inhibitors","score":0.8489999771118164},{"id":"https://openalex.org/keywords/factor-ix-inhibitors","display_name":"factor IX inhibitors","score":1.0},{"id":"https://openalex.org/keywords/hemophilia","display_name":"hemophilia","score":0.7110000252723694},{"id":"https://openalex.org/keywords/acquired-hemophilia","display_name":"acquired hemophilia","score":0.6510000228881836},{"id":"https://openalex.org/keywords/activated-prothrombin-complex-concentrate","display_name":"activated prothrombin complex concentrate","score":0.871999979019165},{"id":"https://openalex.org/keywords/bleeding-events","display_name":"bleeding events","score":0.6970000267028809},{"id":"https://openalex.org/keywords/surgical-bleeding","display_name":"surgical bleeding","score":0.5059999823570251},{"id":"https://openalex.org/keywords/hiv-seroprevalence","display_name":"HIV seroprevalence","score":0.824999988079071},{"id":"https://openalex.org/keywords/hepatitis-c","display_name":"hepatitis C","score":0.6330000162124634},{"id":"https://openalex.org/keywords/secondary-immune-response","display_name":"secondary immune response","score":0.8790000081062317},{"id":"https://openalex.org/keywords/thrombogenic-risk","display_name":"thrombogenic risk","score":0.6970000267028809},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.49399998784065247},{"id":"https://openalex.org/keywords/drug-tolerance","display_name":"drug tolerance","score":0.6010000109672546}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9162343740463257},{"id":"https://openalex.org/C2781221834","wikidata":"https://www.wikidata.org/wiki/Q425360","display_name":"Factor IX","level":2,"score":0.8023768663406372},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.5906440615653992},{"id":"https://openalex.org/C2992435398","wikidata":"https://www.wikidata.org/wiki/Q6934595","display_name":"Multicenter study","level":3,"score":0.5316501259803772},{"id":"https://openalex.org/C50440223","wikidata":"https://www.wikidata.org/wiki/Q1475848","display_name":"Risk factor","level":2,"score":0.5269452333450317},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5073437094688416},{"id":"https://openalex.org/C2777451964","wikidata":"https://www.wikidata.org/wiki/Q2141450","display_name":"Seroconversion","level":3,"score":0.5068712830543518},{"id":"https://openalex.org/C2778385053","wikidata":"https://www.wikidata.org/wiki/Q134003","display_name":"Haemophilia","level":2,"score":0.48942795395851135},{"id":"https://openalex.org/C32611913","wikidata":"https://www.wikidata.org/wiki/Q2166189","display_name":"Titer","level":3,"score":0.46721211075782776},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4640582799911499},{"id":"https://openalex.org/C2992139802","wikidata":"https://www.wikidata.org/wiki/Q179217","display_name":"Clotting factor","level":2,"score":0.44981884956359863},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.42509379982948303},{"id":"https://openalex.org/C3018359225","wikidata":"https://www.wikidata.org/wiki/Q7113249","display_name":"Poor responder","level":2,"score":0.4179893732070923},{"id":"https://openalex.org/C2777091921","wikidata":"https://www.wikidata.org/wiki/Q2044524","display_name":"Prothrombin complex concentrate","level":4,"score":0.41735148429870605},{"id":"https://openalex.org/C2779936836","wikidata":"https://www.wikidata.org/wiki/Q890200","display_name":"Coagulopathy","level":2,"score":0.41326022148132324},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.32937002182006836},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1782078742980957},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.1383167803287506},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.11372426152229309},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.077595055103302},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000906","descriptor_name":"Antibodies","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D001779","descriptor_name":"Blood Coagulation Factors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001779","descriptor_name":"Blood Coagulation Factors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002836","descriptor_name":"Hemophilia B","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D002836","descriptor_name":"Hemophilia B","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002836","descriptor_name":"Hemophilia B","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D005164","descriptor_name":"Factor IX","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D005169","descriptor_name":"Factor VIII","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D005602","descriptor_name":"France","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006467","descriptor_name":"Hemophilia A","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006467","descriptor_name":"Hemophilia A","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006467","descriptor_name":"Hemophilia A","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1055/s-0038-1656122","doi":"https://doi.org/10.1055/s-0038-1656122","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-0038-1656122","pdf_url":null,"source":{"id":"https://openalex.org/S206235894","display_name":"Thrombosis and Haemostasis","issn_l":"0340-6245","issn":["0340-6245","2567-689X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Thrombosis and Haemostasis","raw_type":"journal-article"},{"id":"pmid:9241742","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9241742","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Thrombosis and haemostasis","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W82500787","https://openalex.org/W226534966","https://openalex.org/W1527938269","https://openalex.org/W1571639926","https://openalex.org/W1654758240","https://openalex.org/W1950259194","https://openalex.org/W1988379852","https://openalex.org/W1998823334","https://openalex.org/W2002364113","https://openalex.org/W2010805585","https://openalex.org/W2017164294","https://openalex.org/W2032129012","https://openalex.org/W2050510640","https://openalex.org/W2052884190","https://openalex.org/W2073590516","https://openalex.org/W2084151970","https://openalex.org/W2089956991","https://openalex.org/W2166203567","https://openalex.org/W2278553352","https://openalex.org/W2321411638","https://openalex.org/W2337290468","https://openalex.org/W2403444710","https://openalex.org/W2415863444","https://openalex.org/W2460531945","https://openalex.org/W2734698134","https://openalex.org/W3028099557","https://openalex.org/W3101786636"],"related_works":["https://openalex.org/W2017345748","https://openalex.org/W2140742163","https://openalex.org/W2147073169","https://openalex.org/W2102387943","https://openalex.org/W1981344254","https://openalex.org/W1970441900","https://openalex.org/W2110815781","https://openalex.org/W2066669083","https://openalex.org/W2140779455","https://openalex.org/W2039064237"],"abstract_inverted_index":{"Factor":[0],"VIII":[1],"or":[2,107,140,272],"factor":[3,142],"IX":[4],"replacement":[5],"is":[6,85],"frequently":[7],"impossible":[8],"in":[9,35,50,81,109,114,120,145,162,167,218,234,242,262,273],"inhibitor-developing":[10,270],"hemophiliacs,":[11],"because":[12],"of":[13,16,26,41,75,178,188,198,203,214,220,229,232,269],"the":[14,17,27,32,39,45,73,152,190,195,204,212,226,230,238,243,250,263,267],"level":[15],"inhibitor":[18],"titer.":[19],"Activated":[20],"prothrombin":[21],"complex":[22],"concentrates":[23],"are":[24,58],"one":[25],"available":[28],"options":[29,265],"to":[30,71,194,255,260],"treat":[31],"bleeding":[33,89],"episodes":[34,111,116,122,164],"such":[36,53],"patients.":[37],"However,":[38],"efficacy":[40,102,248],"these":[42],"products":[43],"and":[44,83,118,125,144,185,236,249],"associated":[46],"thrombogenic":[47],"risk,":[48],"particularly":[49,237],"prolonged":[51],"administration":[52,213],"as":[54,105,134,151,160],"employed":[55],"during":[56],"surgeries,":[57],"important":[59],"concerns":[60],"for":[61,186,266],"hemophilia":[62,99],"care":[63],"providers.":[64],"We":[65],"performed":[66,131],"a":[67,135,258],"multicenter":[68],"retrospective":[69],"study":[70,223],"evaluate":[72],"use":[74,197,231],"FEIBA":[76,133,148,215,233],"(Factor":[77],"Eight":[78],"Bypassing":[79],"Activity)":[80],"France,":[82,235],"data":[84],"presented":[86],"on":[87],"433":[88],"episodes,":[90],"including":[91],"surgical":[92,127],"procedures,":[93],"concerning":[94],"60":[95],"patients":[96,176,205,244],"from":[97],"15":[98],"centers.":[100],"The":[101,156,246],"was":[103,149,158,216],"judged":[104],"good":[106,161,247],"excellent":[108,251],"352":[110],"(81.3%),":[112],"poor":[113],"73":[115],"(16.9%)":[117],"non-existent":[119],"8":[121],"(1.8%).":[123],"Minor":[124],"major":[126],"procedures":[128],"were":[129,172,183,206],"successfully":[130],"using":[132],"second-line":[136],"therapy":[137],"after":[138,211],"human":[139],"porcine":[141],"VIII,":[143],"some":[146],"occasions":[147],"utilized":[150],"only":[153],"substitution":[154],"product.":[155],"tolerance":[157,252],"assessed":[159],"428":[163],"(98.8%),":[165],"but":[166],"5":[168],"cases":[169],"adverse":[170],"effects":[171],"reported.":[173],"Only":[174],"3":[175],"out":[177,225],"52":[179],"regularly":[180],"evaluated":[181],"(5.8%)":[182],"HIV-seropositive,":[184],"two":[187],"them":[189],"seroconversion":[191],"occurred":[192],"prior":[193],"first":[196],"FEIBA.":[199],"In":[200],"contrast,":[201],"80.4%":[202],"HCV-seropositive.":[207],"An":[208],"anamnestic":[209],"response":[210],"noted":[217],"31.5%":[219],"cases.":[221],"This":[222],"points":[224],"main":[227],"features":[228],"low":[239],"HIV":[240],"seroprevalence":[241],"treated.":[245],"still":[253],"confer":[254],"this":[256],"product":[257],"place":[259],"consider":[261],"therapeutic":[264],"treatment":[268],"hemophiliacs":[271],"acquired":[274],"hemophilia.":[275]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":10},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":12}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}